
Why Onboarding Is A Ramp To Platform Engineering
The Age Of Onboarding
Back when Generation-X started work at around the end of the 1970s, workers had to (mostly) like it or lump it when any change occured. Fast forward half a century or so and we're a little more humane. This is the age of onboarding i.e. a time when formalized procedures are in place to make sure new work factors of all kinds are introduced carefully and compassionately to familiarize people with change. By providing onboarding meetings, documents, how-to videos and more, what we used to casually call 'induction' is now a more sensitive process that is designed to improve employee retention and job satisfaction.
Of all the changes happening now at the coder's command line (and this is not a story about AI, mercifully), the elevation to platform engineering is perhaps one of the most important factors to onboard software developers for. By providing self-service software toolsets and workflow items via an internal developer portal, developers get a nicely pre-paved path with automations that abstract the complexity of infrastructure provisioning and management that they might otherwise have to also attend do.
But as good as platform engineering is, it's still a change, so organizations will need to be sensitive to the initial user interaction that developers have with the platform approach, which can significantly limit adoption.
Innovators & Early Adopters
According to the diffusion of innovations theory, there is a 16% user adoption point that represents a critical threshold where an innovation moves from the early market to the mainstream market. This occurs because the initial adoption is often driven by 'innovators and early adopters' who are willing to accept unpolished experiences due to curiosity or strategic vision; however, broader adoption requires appealing to the majority with more refined solutions.
'The majority of early adopters, comprising around a third of users, becomes essential for achieving mainstream success. They demand clear value, proven stability and intuitive usability (even it comes with a few rough edges). This transformation in user expectations creates a gap that many platform engineering initiatives fail to address. Initial adopters may overlook issues or points of friction in the onboarding experience, but mainstream users will not,' explained Bryan Ross, field CTO, GitLab.
Ross says that any software platform's 'brand identity' represents users' first point of contact with an application, tool or service. He thinks that strong platform brand identities communicate benefits than any explanation or clarification of underlying infrastructure. He asks us to consider software brand names like "Runway" (a technology that coalesces various cloud infrastructure elements to streamline deployment pipelines and processes) that showcased the intended value proposition of the service, rather than using any more technically explanatory jargon like "Kubernetes Pipeline Producer', for example.
Version 9.120.80, No Thanks
'Technology teams working to deliver, implement, augment or dovetail with platform engineering principles should avoid common naming shortcomings that can undermine a platform's credibility,' said Ross. 'Showing the number of versions in the name suggests that past iterations have failed, calling durability into question. Similarly, choosing an unimaginative three-letter acronym combination makes a platform indistinguishable from other abbreviations, while technology-aimed names indicate a prioritization of systems over user requirements,' said Ross.
Because users' initial perceptions are usually visual, he underlines the fact that outdated or inconsistent interfaces can deter users, despite strong underlying functionality.
'Organizations often dedicate months to refining platform capabilities while ignoring the most fundamental need: creation of a smooth, effortless experience. I've seen this pattern across companies of all sizes and sectors,' clarified GitLab's Ross. 'The most common obstacles include manual onboarding processes for a platform claiming to be self-service. When full automation isn't realistic, handle human tasks asynchronously as much as possible to avoid long approval workflows or restrictions that prevent instant testing. One solution is to offer immediate, temporary access to your platform free of charge for 30 days, which is usually enough time for someone to determine if your platform is a fit for their needs.'
Training, Not An Entry Barrier
Another common mistake is when a team can be defined to require training before using any given platform or service. The advice here is that while training is (almost always) useful, it should be required after joining the platform rather than being a barrier to entry.
Even the best solutions require support and immediate, responsive support is the best way to build trust with users. The main objectives during support interactions should be to reduce user frustration and maintain momentum. Ross and team advocate the need for a strong support structure using diverse channels, they provide the following four cornerstones:
Ross says that organizations aiming to roll out new platform engineering toolsets (and this is probably advice that could apply to the deployment of any new element of IT services at any level) should stay reachable through each users' preferred communication methods, even if that requires monitoring several platforms.
'The bedrock of platform engineering excellence isn't choosing optimal technologies. It's rooted in empathy and understanding. The best platform teams are the ones that build a deep understanding of the daily realities of developers, security professionals and operations specialists. They realize the constraints these teams must go through, their success measurements and the obstacles that create the most friction,' concluded Ross. 'Companies that prioritize user experience from the start gain significant advantages in adoption rates and user engagement. By establishing smooth onboarding workflows, comprehensive documentation and reliable support networks, teams convert the user experience from being a challenging one to an excellent one.'
Platform engineering has made plenty of headlines across the technology and business media over the last year or so, it has also impacted the social discussion threads among many technology communities (there was little talk of little else at the last couple of Cloud Native Computing Foundation symposia) and of course it has actually physically impacted the way many software engineering teams operate.
Because platform engineering is a significant change, an additional degree of forethought is sure to go along way. If we take more care upfront in terms of onboarding, then it should be plain sailing ahead.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Medical Devices & Supplies - Specialty company Inspire Medical Systems (NYSE:INSP) jumped 3%. Is now the time to buy Inspire Medical Systems? Access our full analysis report here, it's free. Drug Development Inputs & Services company UFP Technologies (NASDAQ:UFPT) jumped 3.5%. Is now the time to buy UFP Technologies? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Globus Medical (NYSE:GMED) jumped 3%. Is now the time to buy Globus Medical? Access our full analysis report here, it's free. Medical Devices & Supplies - Diversified company Neogen (NASDAQ:NEOG) jumped 3.4%. Is now the time to buy Neogen? Access our full analysis report here, it's free. Dental Equipment & Technology company Dentsply Sirona (NASDAQ:XRAY) jumped 3.1%. Is now the time to buy Dentsply Sirona? Access our full analysis report here, it's free. Zooming In On UFP Technologies (UFPT) UFP Technologies's shares are very volatile and have had 24 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 7 days ago when the stock gained 11.9% on the news that the company posted record second-quarter results and beat analyst profit expectations. The medical products company reported a 37.2% surge in sales to $151.2 million compared to the same period last year. Its adjusted earnings per share reached $2.50, which surpassed Wall Street's consensus estimate of $2.25. This strong performance was primarily driven by a 46% jump in its MedTech business, fueled by demand in areas like robotic-assisted surgery. However, the results included a 20% decline in its Advanced Components division, and the company noted increased labor costs pressured margins. UFP Technologies is down 10.2% since the beginning of the year, and at $221.03 per share, it is trading 38.3% below its 52-week high of $358.42 from September 2024. Investors who bought $1,000 worth of UFP Technologies's shares 5 years ago would now be looking at an investment worth $5,057. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Yahoo
23 minutes ago
- Yahoo
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Therapeutics company Moderna (NASDAQ:MRNA) jumped 3.1%. Is now the time to buy Moderna? Access our full analysis report here, it's free. Surgical Equipment & Consumables - Specialty company Teleflex (NYSE:TFX) jumped 4.1%. Is now the time to buy Teleflex? Access our full analysis report here, it's free. Dental Equipment & Technology company Envista (NYSE:NVST) jumped 3.1%. Is now the time to buy Envista? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Enovis (NYSE:ENOV) jumped 3.5%. Is now the time to buy Enovis? Access our full analysis report here, it's free. Health Insurance Providers company UnitedHealth (NYSE:UNH) jumped 3%. Is now the time to buy UnitedHealth? Access our full analysis report here, it's free. Zooming In On Teleflex (TFX) Teleflex's shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 6 months ago when the stock dropped 22.9% on the news that the company reported disappointing fourth-quarter results, with revenue missing expectations by a significant margin. On a constant currency basis, revenue increased 3.2%, but this still fell short of Wall Street's estimates. Weak demand in Interventional Urology wiped out gains in the Interventional and Surgical units. Looking ahead, the company's 2025 revenue guidance implies little to no growth, with management projecting revenue to be flat to slightly up. Overall, this was a weaker quarter, weighed down by sluggish growth, margin pressures, and a subdued outlook. Teleflex is down 32.8% since the beginning of the year, and at $120.33 per share, it is trading 51.3% below its 52-week high of $247.32 from September 2024. Investors who bought $1,000 worth of Teleflex's shares 5 years ago would now be looking at an investment worth $320.02. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Yahoo
23 minutes ago
- Yahoo
Expedia Group Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore Expedia Group's Fair Values from the Community and select yours Expedia Group (NASDAQ:EXPE) Second Quarter 2025 Results Key Financial Results Revenue: US$3.79b (up 6.4% from 2Q 2024). Net income: US$330.0m (down 14% from 2Q 2024). Profit margin: 8.7% (down from 11% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$2.61 (down from US$2.93 in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Expedia Group Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 25%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Hospitality industry in the US. Performance of the American Hospitality industry. The company's shares are up 4.1% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Expedia Group's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data